Saturday, December 20, 2025
ADVT 
National

No unexpected effects from COVID-19 shots so far

Darpan News Desk The Canadian Press, 08 Jan, 2021 06:26 PM
  • No unexpected effects from COVID-19 shots so far

Health Canada has no reports of unexpected side-effects from patients vaccinated against COVID-19 thus far.

"There haven't been any serious adverse events, or even the mild and moderate adverse events, that have been out of line or different than what we've seen in the clinical trials," Dr. Supriya Sharma said in an interview with The Canadian Press Friday.

Sharma, Health Canada's chief medical adviser, is overseeing the vaccine review process.

She said experts look for two things when reviewing data after vaccines are given. The first is whether anything happens that was not observed during the clinical trials, and the second is whether the side-effects that were documented during the trials are more severe or greater in number than what the trials saw.

The answer to both questions in Canada so far is no, said Sharma.

"It seems that the clinical trials are pretty representative," she said.

The most common side-effects from the vaccines are short-term fever, pain at the injection site, headache and fatigue. Most subside within 24 hours.

Health Canada approved two vaccines for COVID-19 in December, including one from Pfizer and BioNTech and a second from Moderna.

Vaccinations began Dec. 14, and data aggregated by University of Saskatchewan student Noah Little shows about 230,000 doses have been given so far. Most of the first doses went to front-line hospital staff and long-term care workers and a smaller number of long-term care residents.

Vaccines began reaching some First Nations and northern territories this week.

Health Canada continues to review data from two other vaccine developers, AstraZeneca and Johnson & Johnson, but is still awaiting more data from the companies. Sharma said she can't say when Health Canada would be ready to make a decision about either one.

Both companies are expected to complete Phase 3 clinical trials in the United States this month.

MORE National ARTICLES

High-risk offender Kristjon Olson back in custody: Surrey RCMP

High-risk offender Kristjon Olson back in custody: Surrey RCMP
On May 22, 2020, Surrey RCMP issued a public warning advising that high-risk sex offender, Kristjon Olson, was released from custody and would be residing in Surrey.

High-risk offender Kristjon Olson back in custody: Surrey RCMP

Vancouver Police investigates hit and run as pedestrian clings to life

Vancouver Police investigates hit and run as pedestrian clings to life
The pedestrian, a 47-year-old man from Vancouver, was taken to hospital with serious, life-threatening injuries.

Vancouver Police investigates hit and run as pedestrian clings to life

Border officer says Meng had choice to share codes

Border officer says Meng had choice to share codes
The B.C. Supreme Court is hearing evidence this week that Meng's defence team hopes will bolster an argument they will make next year during extradition proceedings that she was subject to an abuse of process.

Border officer says Meng had choice to share codes

WATCH: Canada To Welcome Over 1 Million New Immigrants in 3 years

WATCH: Canada To Welcome Over 1 Million New Immigrants in 3 years
 Between 2021 and 2023, the goal is to admit upwards of 1.2 million new permanent residents.

WATCH: Canada To Welcome Over 1 Million New Immigrants in 3 years

Canadians need to cut contacts by a quarter: Tam

Canadians need to cut contacts by a quarter: Tam
The modelling indicates that at current rates of in-person socializing, Canada could see COVID-19 case counts increase to8,000 per day come early December.

Canadians need to cut contacts by a quarter: Tam

Scientists ID markers in blood for severe COVID-19

Scientists ID markers in blood for severe COVID-19
The study, which has been published online and is currently in the final stages of peer review for the journal Critical Care, concludes that the presence of the virus's RNA in blood is "associated to critical illness."

Scientists ID markers in blood for severe COVID-19